1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Biologic Therapeutics Market, By Product
5.1 Introduction
5.2 Gene Therapy
5.3 Cell Therapy
5.4 Vaccines
5.5 Antibody Therapeutics
5.6 Other Products
6 Global Biologic Therapeutics Market, By Type
6.1 Introduction
6.2 Allergenic Extracts
6.3 Blood Products
6.4 Human Cells and Tissues
6.5 Protein
6.6 Xenotransplantation Products
6.7 Other Types
7 Global Biologic Therapeutics Market, By Application
7.1 Introduction
7.2 Autoimmune Diseases
7.3 Infectious Diseases
7.4 Cancer
7.5 Other Applications
8 Global Biologic Therapeutics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 AbbVie Inc
10.2 Amgen Inc.
10.3 AstraZeneca Plc
10.4 Aurobindo Pharma Ltd.
10.5 Baxter International Inc
10.6 Biocon Ltd.
10.7 Celltrion Healthcare Co. Ltd.
10.8 GlaxoSmithKline Plc
10.9 Merck and Co. Inc
10.10 Novartis AG
10.11 Pfizer Inc
10.12 Precision Biologics Inc
10.13 Samsung Electronics Co. Ltd
List of Tables
Table 1 Global Biologic Therapeutics Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
Table 4 Global Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
Table 5 Global Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
Table 6 Global Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
Table 7 Global Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
Table 8 Global Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
Table 9 Global Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
Table 10 Global Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
Table 11 Global Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
Table 12 Global Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
Table 13 Global Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
Table 14 Global Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
Table 15 Global Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
Table 16 Global Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
Table 17 Global Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 18 Global Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
Table 19 Global Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
Table 20 North America Biologic Therapeutics Market Outlook, By Country (2021-2030) ($MN)
Table 21 North America Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
Table 22 North America Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
Table 23 North America Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
Table 24 North America Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
Table 25 North America Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
Table 26 North America Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
Table 27 North America Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
Table 28 North America Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
Table 29 North America Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
Table 30 North America Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
Table 31 North America Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
Table 32 North America Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
Table 33 North America Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
Table 34 North America Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
Table 35 North America Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
Table 36 North America Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 37 North America Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
Table 38 North America Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
Table 39 Europe Biologic Therapeutics Market Outlook, By Country (2021-2030) ($MN)
Table 40 Europe Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
Table 41 Europe Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
Table 42 Europe Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
Table 43 Europe Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
Table 44 Europe Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
Table 45 Europe Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
Table 46 Europe Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
Table 47 Europe Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
Table 48 Europe Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
Table 49 Europe Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
Table 50 Europe Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
Table 51 Europe Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
Table 52 Europe Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
Table 53 Europe Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
Table 54 Europe Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
Table 55 Europe Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 56 Europe Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
Table 57 Europe Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
Table 58 Asia Pacific Biologic Therapeutics Market Outlook, By Country (2021-2030) ($MN)
Table 59 Asia Pacific Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
Table 60 Asia Pacific Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
Table 61 Asia Pacific Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
Table 62 Asia Pacific Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
Table 63 Asia Pacific Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
Table 64 Asia Pacific Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
Table 65 Asia Pacific Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
Table 66 Asia Pacific Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
Table 67 Asia Pacific Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
Table 68 Asia Pacific Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
Table 69 Asia Pacific Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
Table 70 Asia Pacific Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
Table 71 Asia Pacific Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
Table 72 Asia Pacific Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
Table 73 Asia Pacific Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
Table 74 Asia Pacific Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 75 Asia Pacific Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
Table 76 Asia Pacific Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
Table 77 South America Biologic Therapeutics Market Outlook, By Country (2021-2030) ($MN)
Table 78 South America Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
Table 79 South America Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
Table 80 South America Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
Table 81 South America Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
Table 82 South America Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
Table 83 South America Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
Table 84 South America Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
Table 85 South America Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
Table 86 South America Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
Table 87 South America Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
Table 88 South America Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
Table 89 South America Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
Table 90 South America Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
Table 91 South America Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
Table 92 South America Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
Table 93 South America Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 94 South America Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
Table 95 South America Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
Table 96 Middle East & Africa Biologic Therapeutics Market Outlook, By Country (2021-2030) ($MN)
Table 97 Middle East & Africa Biologic Therapeutics Market Outlook, By Product (2021-2030) ($MN)
Table 98 Middle East & Africa Biologic Therapeutics Market Outlook, By Gene Therapy (2021-2030) ($MN)
Table 99 Middle East & Africa Biologic Therapeutics Market Outlook, By Cell Therapy (2021-2030) ($MN)
Table 100 Middle East & Africa Biologic Therapeutics Market Outlook, By Vaccines (2021-2030) ($MN)
Table 101 Middle East & Africa Biologic Therapeutics Market Outlook, By Antibody Therapeutics (2021-2030) ($MN)
Table 102 Middle East & Africa Biologic Therapeutics Market Outlook, By Other Products (2021-2030) ($MN)
Table 103 Middle East & Africa Biologic Therapeutics Market Outlook, By Type (2021-2030) ($MN)
Table 104 Middle East & Africa Biologic Therapeutics Market Outlook, By Allergenic Extracts (2021-2030) ($MN)
Table 105 Middle East & Africa Biologic Therapeutics Market Outlook, By Blood Products (2021-2030) ($MN)
Table 106 Middle East & Africa Biologic Therapeutics Market Outlook, By Human Cells and Tissues (2021-2030) ($MN)
Table 107 Middle East & Africa Biologic Therapeutics Market Outlook, By Protein (2021-2030) ($MN)
Table 108 Middle East & Africa Biologic Therapeutics Market Outlook, By Xenotransplantation Products (2021-2030) ($MN)
Table 109 Middle East & Africa Biologic Therapeutics Market Outlook, By Other Types (2021-2030) ($MN)
Table 110 Middle East & Africa Biologic Therapeutics Market Outlook, By Application (2021-2030) ($MN)
Table 111 Middle East & Africa Biologic Therapeutics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
Table 112 Middle East & Africa Biologic Therapeutics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 113 Middle East & Africa Biologic Therapeutics Market Outlook, By Cancer (2021-2030) ($MN)
Table 114 Middle East & Africa Biologic Therapeutics Market Outlook, By Other Applications (2021-2030) ($MN)
| ※参考情報 生物学的治療薬とは、生物由来の成分を使用した治療薬のことを指します。これらの治療薬は、遺伝子組換え技術や細胞培養技術を利用して、生物の細胞や組織から抽出したり、選択的に設計したりします。生物学的治療薬は、主にタンパク質や抗体、細胞治療製品などが含まれており、従来の化学合成薬とは異なる分子の構造を持っています。 生物学的治療薬には、主にモノクローナル抗体、細胞治療製品、ワクチン、再生医療製品などの種類があります。モノクローナル抗体は、特定の抗原に対して選択的に結合する抗体を指し、これにより疾患の進行を抑制する効果があります。例えば、がんや自己免疫疾患の治療において広く用いられています。 細胞治療製品は、患者自身の細胞やドナーから採取した細胞を用いて行う治療法です。これには、幹細胞治療や免疫細胞療法が含まれ、特にがん治療においては、患者の免疫系を強化し病気と戦う力を向上させる効果が期待されています。 ワクチンは、感染症を予防するために生物学的治療薬の中で非常に重要な位置を占めています。これにより、特定の病原体に対する免疫反応を誘導し、感染を防ぐことが可能になります。最近では新型コロナウイルスのパンデミックに対処するためにmRNAワクチンなど、新しい技術を用いたワクチン開発が進められました。 再生医療製品は、損傷した組織や臓器の再生を目指す治療法です。これには、細胞の再生を促進するための因子や組織工学の技術が応用され、傷ついた組織や器官の修復を助ける目的で開発されています。 生物学的治療薬の用途は非常に広範で、特に癌、自己免疫疾患、感染症、神経疾患、代謝異常などの疾患に対して多くの貢献をしています。これらの薬剤は、効果的な治療となるだけでなく、一般的には副作用が少なく、より標的を絞った治療が可能であるため、患者の生活の質を向上させることが期待されます。 また、関連技術としては、バイオインフォマティクス、遺伝子編集技術、ナノテクノロジーなどがあります。バイオインフォマティクスは、生物学的データを解析・管理するための情報技術を用い、新たな治療対象や治療法の発見に寄与しています。遺伝子編集技術、特にCRISPR技術は、特定の遺伝子を精密に編集することで、遺伝性疾患や癌などの治療に用いられ、その可能性は日々拡大しています。 ナノテクノロジーは、薬剤を病巣部において効果的に届けるための手段として注目されており、特に癌治療においては、ターゲット療法の精度を高める役割を果たしています。 しかし生物学的治療薬には製造の難しさやコストが高いという課題もあります。従来の化学合成薬に比べて製造プロセスが複雑であり、品質管理が非常に重要です。また、これらの治療薬の高い価格は、患者にとって経済的な負担となることがあります。そのため、今後の研究開発においては、より効率的で安価な製造方法の確立が望まれます。 さらに、患者の個別のニーズに応じたオーダーメイド医療の進展が期待されています。生物学的治療薬は、患者の遺伝的背景や疾患の特性に基づいて選択されるべきであり、パーソナライズドメディスンの一環としての役割が重要視されています。 今後、さらなる科学技術の進展によって、生物学的治療薬がより多くの疾患に対して効果を持つ治療選択肢となることが期待されています。それにより、これまでの医学では治癒が困難であった病気に対しても新たな治療の道を開く可能性が広がっています。生物学的治療薬の進展は、医療の未来を大きく変える力を持っていると言えるでしょう。 |
